Anti‐SARS‐CoV‐2 spike immunoglobulin G and immunoglobulin M titers decline as interval from the second inactivated vaccine dose to the onset of illness is prolonged in breakthrough infection patients

BACKGROUND: Understanding of the early immune response in severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) breakthrough infections is limited. METHODS: Ninety‐eight patients with coronavirus disease 2019 (COVID‐19) breakthrough infections were divided into two groups, with intervals from...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Chuan‐cai, He, Zhi‐song, Lei, Wei, Zhu, Jin‐zhou, Zhao, Da‐guo, Kong, Jin‐dan, Wei, Yao, Xu, Ying, Huang, Jian‐An
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113280/
https://www.ncbi.nlm.nih.gov/pubmed/36759335
http://dx.doi.org/10.1111/crj.13590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113280/
https://www.ncbi.nlm.nih.gov/pubmed/36759335
http://dx.doi.org/10.1111/crj.13590

Ejemplares similares